--- title: "Pramodini Medicare Ltd (1286093) — Share Price, Financials & Analysis" symbol: "1286093" company: "Pramodini Medicare Ltd" canonical: "https://tapetide.com/stocks/1286093" isin: "INE2JG601017" nse_symbol: "PRAMODINI" sector: "Healthcare" industry: "Healthcare Services" market_cap_cr: 275.68 generated_at: "2026-09-13T19:09:38.861Z" --- # Pramodini Medicare Ltd (1286093) Canonical page: https://tapetide.com/stocks/1286093 ## Company - **NSE Symbol:** PRAMODINI - **ISIN:** INE2JG601017 - **Sector:** Healthcare - **Industry:** Healthcare Services - **Macro Sector:** Healthcare - **Listed Since:** 2026-08-19 - **Face Value:** ₹10 - **F&O Eligible:** No ## About Incorporated in 2000, Pramodini Medicare Limited is a diagnostic service provider in India offering technology-enabled diagnostic services across radiology, clinical laboratory, and nuclear medicine segments.[1] ## Latest Price - **Price:** ₹118.5 - **Change:** -8.7 (-6.84%) - **Open:** ₹129.4 - **Day High:** ₹130.9 - **Day Low:** ₹117 - **Previous Close:** ₹127.2 - **Volume:** 445200 - **As Of:** 2026-09-11T09:57:41+00:00 ## Key Fundamentals Observed at 2026-09-11T04:33:27.763807Z. - **Market Cap:** ₹275.68 Cr - **Classification:** SME - **P/E (reported):** 16.1 - **Book Value:** ₹52.75 - **Price to Book:** 2.41 - **Dividend Yield:** 0% - **ROE:** 32.69% - **ROCE:** 36.55% - **Debt to Equity:** 0.34 - **Revenue (yearly):** ₹63.4 Cr - **Net Income:** ₹17.4 Cr - **EBITDA:** ₹32 Cr - **52-Week High:** ₹137 - **52-Week Low:** ₹111.55 - **RSI (14):** 56.86 ## Key Insights ### Strengths - Company has a good return on equity (ROE) track record: 3 Years ROE 35.5% - Debtor days have improved from 131 to 102 days. ## Growth Rates | Metric | 1Y | 3Y | 5Y | | --- | --- | --- | --- | | cash flow growth | 14.78% | 157.77% | 6.82% | | ebitda margin growth | -8.53% | 12.23% | — | | net income growth | 56.76% | 145.07% | — | | revenue growth | 64.68% | 20.99% | — | | roce | -4.99% | -2.27% | — | | roe | 4.98% | 30.89% | — | ## Financial Statements ### Profit & Loss All figures in ₹ crore unless the row name says otherwise. | Item | Mar 2024 | Mar 2025 | Mar 2026 | | --- | --- | --- | --- | | Sales | 35 | 38 | 62 | | Expenses | 20 | 17 | 31 | | Operating Profit | 16 | 21 | 31 | | OPM % | 44 | 55 | 50 | | Other Income | 1 | 0 | 1 | | Interest | 2 | 1 | 1 | | Depreciation | 4 | 4 | 7 | | Profit before tax | 10 | 16 | 23 | | Tax % | 29 | 29 | 25 | | Net Profit | 7 | 11 | 17 | | EPS in Rs | 5.4 | 85.89 | 10.41 | | Dividend Payout % | 0 | 0 | 0 | ### Balance Sheet All figures in ₹ crore unless the row name says otherwise. | Item | Mar 2024 | Mar 2025 | Mar 2026 | | --- | --- | --- | --- | | Equity Capital | 1 | 1 | 17 | | Reserves | 23 | 34 | 36 | | Borrowings | 12 | 11 | 18 | | Other Liabilities | 12 | 10 | 23 | | Total Liabilities | 49 | 56 | 94 | | Fixed Assets | 16 | 22 | 44 | | CWIP | 0 | 0 | 0 | | Investments | 0 | 0 | 0 | | Other Assets | 33 | 35 | 49 | | Total Assets | 49 | 56 | 94 | ### Cash Flow All figures in ₹ crore unless the row name says otherwise. | Item | Mar 2024 | Mar 2025 | Mar 2026 | | --- | --- | --- | --- | | Cash from Operating Activity | 10 | 22 | 25 | | Cash from Investing Activity | -1 | -15 | -31 | | Cash from Financing Activity | -11 | -2 | 6 | | Net Cash Flow | -2 | 5 | 0 | | Free Cash Flow | 9 | 12 | -4 | | CFO/OP | 83 | 127 | 98 | ### Ratios | Item | Mar 2024 | Mar 2025 | Mar 2026 | | --- | --- | --- | --- | | Debtor Days | 186 | 107 | 102 | | Cash Conversion Cycle | 186 | 107 | 102 | | Working Capital Days | 16 | 0 | 2 | | ROCE % | — | 41 | 42 | ## Shareholding Pattern ### Quarterly | Category | Apr 2026 | Aug 2026 | | --- | --- | --- | | Promoters | 85.71% | 85.71% | | FIIs | 0% | 2.84% | | DIIs | 0% | 0% | | Government | 0% | 0% | | Public | 0% | 0% | | Others | 14.29% | 11.45% | | No. of Shareholders | 12 | 12 | ## Technical Indicators Derived from daily closing prices and recomputed each trading session; values move with the market. - **Overall Signal:** Sell - **Buy / Neutral / Sell:** 0 / 16 / 3 ### Moving Averages — summary: **Sell** | Indicator | Value | Signal | | --- | --- | --- | | SMA (10) | 119.88 | Sell | | EMA (10) | 121.32 | Sell | | SMA (20) | — | Neutral | | EMA (20) | — | Neutral | | SMA (50) | — | Neutral | | EMA (50) | — | Neutral | | SMA (100) | — | Neutral | | EMA (100) | — | Neutral | | SMA (200) | — | Neutral | | EMA (200) | — | Neutral | ### Oscillators — summary: **Sell** | Indicator | Value | Signal | | --- | --- | --- | | RSI (14) | 44.35 | Neutral | | MACD (12,26,9) | — | Neutral | | Stochastic (14,3,3) | 51.41 | Neutral | | ADX (14) | — | Neutral | | Williams %R (14) | -72.69 | Neutral | | ATR (14) | 6.68 | High Volatility | | ROC (12) | -2.27 | Sell | | Stoch RSI (14) | — | Neutral | | UO (7,14,28) | — | Neutral | ## Filings & Documents ### Other Documents | Date | Document | | --- | --- | | 9 Sep - Board approved SPV incorporation, Neosoft 32 Slice CT scanner purchase, and internal auditor appointment for FY2026-27. | [Outcome of Board Meeting 9 Sep - Board approved SPV incorporation, Neosoft 32 Slice CT scanner purchase, and internal auditor appointment for FY2026-27.](https://nsearchives.nseindia.com/corporate/PRAMODINI26_09092026133943_BMOutcome.pdf) | | 9 Sep - Board approved SPV incorporation, CT scanner purchase for Maharajganj, and internal auditor appointment on 09 September 2026. | [Appointment 9 Sep - Board approved SPV incorporation, CT scanner purchase for Maharajganj, and internal auditor appointment on 09 September 2026.](https://nsearchives.nseindia.com/corporate/PRAMODINI26_09092026134328_BMOutcome.pdf) | --- Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:09:38.861Z.